159 related articles for article (PubMed ID: 2872804)
1. Terazosin: an effective once-daily monotherapy for the treatment of hypertension.
Dauer AD
Am J Med; 1986 May; 80(5B):29-34. PubMed ID: 2872804
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension.
Deger G
Am J Med; 1986 May; 80(5B):62-7. PubMed ID: 2872809
[TBL] [Abstract][Full Text] [Related]
3. Comparative trials of terazosin with other antihypertensive agents.
Ruoff G
Am J Med; 1986 May; 80(5B):42-8. PubMed ID: 2872806
[TBL] [Abstract][Full Text] [Related]
4. Experience with terazosin administered in combination with other antihypertensive agents.
Chrysant SG
Am J Med; 1986 May; 80(5B):55-61. PubMed ID: 2872808
[TBL] [Abstract][Full Text] [Related]
5. Cumulative experience with terazosin administered in combination with diuretics.
Rudd P
Am J Med; 1986 May; 80(5B):49-54. PubMed ID: 2872807
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive therapy with once-daily administration of terazosin, a new alpha 1-adrenergic-receptor blocker.
Abraham PA; Halstenson CE; Matzke GR; Napier JL; Keane WF
Pharmacotherapy; 1985; 5(5):285-9. PubMed ID: 2866492
[TBL] [Abstract][Full Text] [Related]
7. Long-term experience with terazosin for treatment of mild to moderate hypertension.
Mersey JH
Am J Med; 1986 May; 80(5B):68-72. PubMed ID: 2872810
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of intravenous terazosin in hypertensive patients. A preliminary report.
Cohen A
Am J Med; 1986 May; 80(5B):86-93. PubMed ID: 2872814
[TBL] [Abstract][Full Text] [Related]
9. Effect of terazosin on serum lipids.
Deger G
Am J Med; 1986 May; 80(5B):82-5. PubMed ID: 2872813
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of terazosin as an antihypertensive agent.
Luther RR; Glassman HN; Jordan DC; Sperzel WD
Am J Med; 1986 May; 80(5B):73-6. PubMed ID: 2872811
[TBL] [Abstract][Full Text] [Related]
11. Effect of withdrawal of terazosin therapy in patients with hypertension.
Ruoff G
Am J Med; 1986 May; 80(5B):35-41. PubMed ID: 2872805
[TBL] [Abstract][Full Text] [Related]
12. Overall safety of terazosin as an antihypertensive agent.
Sperzel WD; Glassman HN; Jordan DC; Luther RR
Am J Med; 1986 May; 80(5B):77-81. PubMed ID: 2872812
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials with terazosin. General methods.
Sperzel WD; Luther RR; Glassman HN
Am J Med; 1986 May; 80(5B):25-8. PubMed ID: 2872803
[TBL] [Abstract][Full Text] [Related]
14. Concomitant administration of terazosin and atenolol for the treatment of essential hypertension.
Holtzman JL; Kaihlanen PM; Rider JA; Lewin AJ; Spindler JS; Oberlin JA
Arch Intern Med; 1988 Mar; 148(3):539-43. PubMed ID: 3277569
[TBL] [Abstract][Full Text] [Related]
15. The relationship between terazosin dose and blood pressure response in hypertensive patients.
Achari R; Hosmane B; Bonacci E; O'Dea R
J Clin Pharmacol; 2000 Oct; 40(10):1166-72. PubMed ID: 11028256
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral and intravenous terazosin and head-up tilt on blood pressure responses in patients with hypertension.
Achari R; Hosmane B; Linnen P; Cavanaugh J; Baroldi P; Cohen A
J Clin Pharmacol; 1998 Jun; 38(6):545-53. PubMed ID: 9650545
[TBL] [Abstract][Full Text] [Related]
17. Terazosin: a new alpha 1-blocker for the treatment of hypertension: a review of randomized, controlled clinical trials of once-daily administration as monotherapy.
Luther RR; Glassman HN; Sperzel WD; Steinberg FJ; Horton JK; Jordan DC
J Hypertens Suppl; 1986 Dec; 4(5):S494-7. PubMed ID: 2883273
[TBL] [Abstract][Full Text] [Related]
18. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
Luther RR; Glassman HN; Estep CB; Maurath CJ; Jordan DC
Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723
[TBL] [Abstract][Full Text] [Related]
19. Terazosin, a new selective alpha 1-adrenergic blocking agent. Results of long-term treatment in patients with essential hypertension.
Luther RR; Glassman HN; Estep CB; Schmitz PJ; Horton JK; Jordan DC
Am J Hypertens; 1988 Jul; 1(3 Pt 3):237S-240S. PubMed ID: 2901267
[TBL] [Abstract][Full Text] [Related]
20. Alpha 2-agonist versus alpha 1-antagonist in mild-to-moderate hypertension: comparison of transdermal clonidine and terazosin monotherapies.
Harris SI; Alvarez C
Am J Ther; 1997 Jan; 4(1):9-15. PubMed ID: 10423584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
